Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Recombinant human granulocyte macrophage-colony stimulating factor expressed in yeast (sargramostim): A potential ally to combat serious infections.

Damiani G, McCormick TS, Leal LO, Ghannoum MA.

Clin Immunol. 2019 Oct 29:108292. doi: 10.1016/j.clim.2019.108292. [Epub ahead of print] Review.

PMID:
31676420
2.

An uncharacterized region within the N-terminus of mouse TMC1 precludes trafficking to plasma membrane in a heterologous cell line.

Soler DC, Manikandan M, Gopal SR, Sloan AE, McCormick TS, Stepanyan R.

Sci Rep. 2019 Oct 24;9(1):15263. doi: 10.1038/s41598-019-51336-0.

3.

Human Beta Defensins and Cancer: Contradictions and Common Ground.

Ghosh SK, McCormick TS, Weinberg A.

Front Oncol. 2019 May 3;9:341. doi: 10.3389/fonc.2019.00341. eCollection 2019. Review.

4.

Generation of Flp-intm-ready DG44 and Lec 3.2.8.1 CHO cell lines for quick and easy constitutive protein expression.

Soler DC, Young AE, Vahedi-Faridi A, McCormick TS.

Biotechniques. 2018 Jul;65(1):41-46. doi: 10.2144/btn-2018-0075.

5.

Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.

Wang Q, McCormick TS, Ward NL, Cooper KD, Conic R, Xu R.

AMIA Annu Symp Proc. 2018 Apr 16;2017:1734-1743. eCollection 2017.

6.

Conceptual Perspectives: Bacterial Antimicrobial Peptide Induction as a Novel Strategy for Symbiosis with the Human Host.

Ghosh SK, Feng Z, Fujioka H, Lux R, McCormick TS, Weinberg A.

Front Microbiol. 2018 Feb 26;9:302. doi: 10.3389/fmicb.2018.00302. eCollection 2018.

7.

Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A.

Li Y, Golden JB, Camhi MI, Zhang X, Fritz Y, Diaconu D, Ivanco TL, Simon DI, Kikly K, McCormick TS, Wang Y, Ward NL.

J Invest Dermatol. 2018 Feb;138(2):310-315. doi: 10.1016/j.jid.2017.09.021. Epub 2017 Sep 23.

8.

An analysis of gene expression data involving examination of signaling pathways activation reveals new insights into the mechanism of action of minoxidil topical foam in men with androgenetic alopecia.

Stamatas GN, Wu J, Pappas A, Mirmirani P, McCormick TS, Cooper KD, Consolo M, Schastnaya J, Ozerov IV, Aliper A, Zhavoronkov A.

Cell Cycle. 2017;16(17):1578-1584. doi: 10.1080/15384101.2017.1327492. Epub 2017 Jun 8.

9.

The ratio of HLA-DR and VNN2+ expression on CD14+ myeloid derived suppressor cells can distinguish glioblastoma from radiation necrosis patients.

Soler DC, Young AB, Cooper KD, Kerstetter-Fogle A, Barnholtz-Sloan JS, Gittleman H, McCormick TS, Sloan AE.

J Neurooncol. 2017 Aug;134(1):189-196. doi: 10.1007/s11060-017-2508-7. Epub 2017 May 27.

PMID:
28551851
10.

Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4+ CD25high Foxp3+ regulatory T-cells in psoriasis.

Han L, Sugiyama H, Zhang Q, Yan K, Fang X, McCormick TS, Cooper KD, Huang Q.

Australas J Dermatol. 2018 Feb;59(1):e31-e38. doi: 10.1111/ajd.12561. Epub 2017 Mar 15.

11.

Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.

Tacastacas JD, Chan DV, Carlson S, Gerson SL, Dowlati A, Fu P, Lu K, Groft S, Rosenjack J, Honda K, McCormick TS, Cooper KD.

JAMA Dermatol. 2017 May 1;153(5):413-420. doi: 10.1001/jamadermatol.2016.5793. Erratum in: JAMA Dermatol. 2017 May 1;153(5):479.

12.

Does imiquimod pretreatment optimize 308-nm excimer laser (UVB) therapy in psoriasis patients?

Tacastacas JD, Oyetakin-White P, Soler DC, Young A, Groft S, Honda K, Cooper KD, McCormick TS.

Photodermatol Photoimmunol Photomed. 2017 Jul;33(4):193-202. doi: 10.1111/phpp.12299. Epub 2017 Apr 20.

13.

Overexpression of AQP3 and AQP10 in the skin exacerbates psoriasiform acanthosis.

Soler DC, Young AE, Griffith AD, Fu PF, Cooper KD, McCormick TS, Popkin DL.

Exp Dermatol. 2017 Oct;26(10):949-951. doi: 10.1111/exd.13307. Epub 2017 Apr 21.

14.

Antibody and cytokine levels in humans fed on by the common bedbug, Cimex lectularius L.

Sheele JM, Ridge GE, Coppolino K, Bonfield T, Young AB, Gaines SL, McCormick TS.

Parasite Immunol. 2017 Mar;39(3). doi: 10.1111/pim.12411.

15.

Induction of Alternative Proinflammatory Cytokines Accounts for Sustained Psoriasiform Skin Inflammation in IL-17C+IL-6KO Mice.

Fritz Y, Klenotic PA, Swindell WR, Yin ZQ, Groft SG, Zhang L, Baliwag J, Camhi MI, Diaconu D, Young AB, Foster AM, Johnston A, Gudjonsson JE, McCormick TS, Ward NL.

J Invest Dermatol. 2017 Mar;137(3):696-705. doi: 10.1016/j.jid.2016.10.021. Epub 2016 Oct 27.

16.

Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.

Wang Y, Golden JB, Fritz Y, Zhang X, Diaconu D, Camhi MI, Gao H, Dawes SM, Xing X, Ganesh SK, Gudjonsson JE, Simon DI, McCormick TS, Ward NL.

JCI Insight. 2016 Dec 8;1(20):e89384. doi: 10.1172/jci.insight.89384.

17.

Feasibility of carotid artery PET/MRI in psoriasis patients.

Rajiah P, Hojjati M, Lu Z, Kosaraju V, Partovi S, O'Donnell JK, Longenecker C, McComsey GA, Golden JB, Muakkassa F, Santilli S, McCormick TS, Cooper KD, Korman NJ.

Am J Nucl Med Mol Imaging. 2016 Aug 20;6(4):223-33. eCollection 2016.

18.

Expanding the List of Dysregulated Immunosuppressive Cells in Psoriasis.

Soler DC, McCormick TS.

J Invest Dermatol. 2016 Sep;136(9):1749-1751. doi: 10.1016/j.jid.2016.04.029. Review.

19.

Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center.

Santilli S, Kast DR, Grozdev I, Cao L, Feig RL, Golden JB, Debanne SM, Gilkeson RC, Orringer CE, McCormick TS, Ward NL, Cooper KD, Korman NJ.

J Transl Med. 2016 Jul 22;14(1):217. doi: 10.1186/s12967-016-0947-0.

20.

Activated T cells exhibit increased uptake of silicon phthalocyanine Pc 4 and increased susceptibility to Pc 4-photodynamic therapy-mediated cell death.

Soler DC, Ohtola J, Sugiyama H, Rodriguez ME, Han L, Oleinick NL, Lam M, Baron ED, Cooper KD, McCormick TS.

Photochem Photobiol Sci. 2016 Jun 8;15(6):822-31. doi: 10.1039/c6pp00058d. Epub 2016 May 10.

21.

Human papillomavirus oncogenic E6 protein regulates human ╬▓-defensin 3 (hBD3) expression via the tumor suppressor protein p53.

DasGupta T, Nweze EI, Yue H, Wang L, Jin J, Ghosh SK, Kawsar HI, Zender C, Androphy EJ, Weinberg A, McCormick TS, Jin G.

Oncotarget. 2016 May 10;7(19):27430-44. doi: 10.18632/oncotarget.8443.

22.

Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid Arthritis.

Shalev-Malul G, Soler DC, Ting AE, Lehman NA, Barnboym E, McCormick TS, Anthony DD, Lazarus HM, Caplan AI, Breitman M, Singer NG.

Stem Cells Transl Med. 2016 May;5(5):628-31. doi: 10.5966/sctm.2015-0299. Epub 2016 Mar 29.

23.

FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6.

Bhattacharyya S, Ghosh SK, Shokeen B, Eapan B, Lux R, Kiselar J, Nithianantham S, Young A, Pandiyan P, McCormick TS, Weinberg A.

Infect Immun. 2016 Apr 22;84(5):1446-1456. doi: 10.1128/IAI.01311-15. Print 2016 May.

24.

Current knowledge on psoriasis and autoimmune diseases.

Ayala-Fontánez N, Soler DC, McCormick TS.

Psoriasis (Auckl). 2016 Feb 22;6:7-32. doi: 10.2147/PTT.S64950. eCollection 2016. Review.

25.

Case report of individual with cutaneous immunodeficiency and novel 1p36 duplication.

Hatter AD, Soler DC, Curtis C, Cooper KD, McCormick TS.

Appl Clin Genet. 2016 Jan 13;9:1-4. doi: 10.2147/TACG.S90713. eCollection 2016.

26.

Increased, but Functionally Impaired, CD14(+) HLA-DR(-/low) Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells.

Soler DC, Young AB, Fiessinger L, Galimberti F, Debanne S, Groft S, McCormick TS, Cooper KD.

J Invest Dermatol. 2016 Apr;136(4):798-808. doi: 10.1016/j.jid.2015.12.036. Epub 2016 Jan 22.

27.

Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models.

Golden JB, Wang Y, Fritz Y, Diaconu D, Zhang X, Debanne SM, Simon DI, McCormick TS, Ward NL.

J Transl Med. 2015 Dec 16;13:382. doi: 10.1186/s12967-015-0738-z.

28.

Chronic Psoriatic Skin Inflammation Leads to Increased Monocyte Adhesion and Aggregation.

Golden JB, Groft SG, Squeri MV, Debanne SM, Ward NL, McCormick TS, Cooper KD.

J Immunol. 2015 Sep 1;195(5):2006-18. doi: 10.4049/jimmunol.1402307. Epub 2015 Jul 29.

29.

The key role of aquaporin 3 and aquaporin 10 in the pathogenesis of pompholyx.

Soler DC, Bai X, Ortega L, Pethukova T, Nedorost ST, Popkin DL, Cooper KD, McCormick TS.

Med Hypotheses. 2015 May;84(5):498-503. doi: 10.1016/j.mehy.2015.02.006. Epub 2015 Feb 11.

30.

Proteomics of skin proteins in psoriasis: from discovery and verification in a mouse model to confirmation in humans.

Lundberg KC, Fritz Y, Johnston A, Foster AM, Baliwag J, Gudjonsson JE, Schlatzer D, Gokulrangan G, McCormick TS, Chance MR, Ward NL.

Mol Cell Proteomics. 2015 Jan;14(1):109-19. doi: 10.1074/mcp.M114.042242. Epub 2014 Oct 28.

31.

Hyper-inflammation and skin destruction mediated by rosiglitazone activation of macrophages in IL-6 deficiency.

Das LM, Rosenjack J, Au L, Galle PS, Hansen MB, Cathcart MK, McCormick TS, Cooper KD, Silverstein RL, Lu KQ.

J Invest Dermatol. 2015 Feb;135(2):389-399. doi: 10.1038/jid.2014.375. Epub 2014 Sep 3.

32.

Psoriasis and cardiovascular risk factors: increased serum myeloperoxidase and corresponding immunocellular overexpression by Cd11b(+) CD68(+) macrophages in skin lesions.

Cao LY, Soler DC, Debanne SM, Grozdev I, Rodriguez ME, Feig RL, Carman TL, Gilkeson RC, Orringer CE, Kern EF, McCormick TS, Cooper KD, Korman NJ.

Am J Transl Res. 2013 Dec 1;6(1):16-27. eCollection 2013.

33.

Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset.

Soler DC, Sugiyama H, Young AB, Massari JV, McCormick TS, Cooper KD.

Clin Immunol. 2013 Oct;149(1):111-8. doi: 10.1016/j.clim.2013.06.007. Epub 2013 Jul 6.

34.

Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjects.

Ghosh SK, McCormick TS, Eapen BL, Yohannes E, Chance MR, Weinberg A.

Epigenetics. 2013 Jul;8(7):703-9. doi: 10.4161/epi.25028. Epub 2013 May 17.

35.

IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities.

Golden JB, McCormick TS, Ward NL.

Cytokine. 2013 May;62(2):195-201. doi: 10.1016/j.cyto.2013.03.013. Epub 2013 Apr 4. Review.

36.

Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.

Johnston A, Fritz Y, Dawes SM, Diaconu D, Al-Attar PM, Guzman AM, Chen CS, Fu W, Gudjonsson JE, McCormick TS, Ward NL.

J Immunol. 2013 Mar 1;190(5):2252-62. doi: 10.4049/jimmunol.1201505. Epub 2013 Jan 28.

37.

Single administration of lesion-limited high-dose (TURBO) ultraviolet B using the excimer laser: clinical clearing in association with apoptosis of epidermal and dermal T cell subsets in psoriasis.

Kagen M, Cao LY, Oyetakin-White P, Tacastacas JD, Yan C, McCormick TS, Cooper KD.

Photodermatol Photoimmunol Photomed. 2012 Dec;28(6):293-8. doi: 10.1111/j.1600-0781.2012.00692.x.

PMID:
23126290
38.

The yin and yang of human Beta-defensins in health and disease.

Weinberg A, Jin G, Sieg S, McCormick TS.

Front Immunol. 2012 Oct 8;3:294. doi: 10.3389/fimmu.2012.00294. eCollection 2012.

39.

Proteomic and bioinformatic profile of primary human oral epithelial cells.

Ghosh SK, Yohannes E, Bebek G, Weinberg A, Jiang B, Willard B, Chance MR, Kinter MT, McCormick TS.

J Proteome Res. 2012 Nov 2;11(11):5492-502. doi: 10.1021/pr3007254. Epub 2012 Oct 16.

40.

Cutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy.

Huang AY, Myers JT, Barkauskas D, Howell SJ, Oleinick NL, McCormick TS, Cooper KD, Baron ED, Lam M.

Photodiagnosis Photodyn Ther. 2012 Sep;9(3):225-31. doi: 10.1016/j.pdpdt.2012.01.007. Epub 2012 Feb 23.

41.

Chronic skin-specific inflammation promotes vascular inflammation and thrombosis.

Wang Y, Gao H, Loyd CM, Fu W, Diaconu D, Liu S, Cooper KD, McCormick TS, Simon DI, Ward NL.

J Invest Dermatol. 2012 Aug;132(8):2067-75. doi: 10.1038/jid.2012.112. Epub 2012 May 10.

42.

Regulation generation: the suppressive functions of human regulatory T cells.

Goodman WA, Cooper KD, McCormick TS.

Crit Rev Immunol. 2012;32(1):65-79. Review.

43.

Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditions.

Loyd CM, Diaconu D, Fu W, Adams GN, Brandt E, Knutsen DA, Wolfram JA, McCormick TS, Ward NL.

Int J Clin Exp Pathol. 2012;5(1):1-11. Epub 2012 Jan 1.

44.

Proteomic signatures of human oral epithelial cells in HIV-infected subjects.

Yohannes E, Ghosh SK, Jiang B, McCormick TS, Weinberg A, Hill E, Faddoul F, Chance MR.

PLoS One. 2011;6(11):e27816. doi: 10.1371/journal.pone.0027816. Epub 2011 Nov 16.

45.

The dark side of regulatory T cells in psoriasis.

Soler DC, McCormick TS.

J Invest Dermatol. 2011 Sep;131(9):1785-6. doi: 10.1038/jid.2011.200.

46.

Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Lam M, Hsia AH, Liu Y, Guo M, Swick AR, Berlin JC, McCormick TS, Kenney ME, Oleinick NL, Cooper KD, Baron ED.

Clin Exp Dermatol. 2011 Aug;36(6):645-51. doi: 10.1111/j.1365-2230.2010.03989.x. Epub 2011 May 30. Review.

47.

Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32).

Chan DV, Somani AK, Young AB, Massari JV, Ohtola J, Sugiyama H, Garaczi E, Babineau D, Cooper KD, McCormick TS.

BMC Biochem. 2011 May 26;12:27. doi: 10.1186/1471-2091-12-27.

48.

Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.

Goodman WA, Young AB, McCormick TS, Cooper KD, Levine AD.

J Immunol. 2011 Mar 15;186(6):3336-45. doi: 10.4049/jimmunol.1001455. Epub 2011 Feb 9.

49.

Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome.

Lam M, Lee Y, Deng M, Hsia AH, Morrissey KA, Yan C, Azzizudin K, Oleinick NL, McCormick TS, Cooper KD, Baron ED.

Adv Hematol. 2010;2010:896161. doi: 10.1155/2010/896161. Epub 2010 Dec 12.

50.

Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.

Ward NL, Loyd CM, Wolfram JA, Diaconu D, Michaels CM, McCormick TS.

Br J Dermatol. 2011 Apr;164(4):750-8. doi: 10.1111/j.1365-2133.2010.10129.x.

Supplemental Content

Loading ...
Support Center